secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2022-01-21T23:59:59+00:00
Accession:  0001564590-22-001848
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Chairman Fuad El-Hibri retires; John Niederhuber named Chairman effective April 1, 2022
--------------------------------------------------------------------------------

- Chairman Fuad El-Hibri retires effective April 1, 2022; no dispute with management or board.
- Dr. John Niederhuber, current Vice Chairman, appointed Chairman effective April 1, 2022.
- Board size reduced from 7 to 6 directors on April 1, 2022.
- El-Hibri to be available as advisor/consultant on terms to be agreed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000156459022001848/0001564590-22-001848-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000156459022001848/apvo-8k_20220121.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-001848

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer